How Healthcare Apps are helping to Improve Clinical Trials

How Healthcare Apps are helping to Improve Clinical Trials

Smartphones are changing our lives every day. Almost every industry is affected by the mobile revolution in one way or another. At George Clinical, we are in the business of clinical trials and we see how even the clinical trial industry is getting a big makeover thanks to healthcare applications that are a growing trend […]

Read More

November 15th, 2016

Bad news for saxagliptin?

Recently, the FDA said it will review possible heart risks associated with saxagliptin, a widely used diabetes drug.

Read More

February 13th, 2014

Lessons from the EVOLVE study

Cinacalcet is a drug that lowers levels of parathyroid hormone, a factor that is increased in almost all people with kidney failure and has been linked to an increased risk of fracture, cardiovascular events and death. It has been hoped that by reducing parathyroid hormone with cinacalcet, the risk of these clinical events will also […]

Read More

August 6th, 2013

required
required
required
required
I wish to subscribe to George Clinical communications.
required

Add George Clinical to your network